Literature DB >> 7851643

The ovarian tumor protein isoforms of Drosophila melanogaster exhibit differences in function, expression, and localization.

G L Sass1, A R Comer, L L Searles.   

Abstract

The Drosophila melanogaster ovarian tumor (otu) gene, required for normal proliferation and differentiation of the female germ-line, encodes two cytoplasmic protein isoforms, 98 and 104 kDa. Mutants with defects in this gene are typically grouped into one of three phenotypic classes: quiescent (germ cells do not proliferate), oncogenic or tumorous (germ-line cells proliferate uncontrollably), and differentiated (germ-line cells initiate but do not complete differentiation). Analysis of transformants expressing only one of the otu isoforms showed that the 104-kDa isoform (otu-104) can rescue all classes of otu mutants, whereas only differentiated mutants are rescued to a significant extent by the 98-kDa isoform (otu-98). Western analysis of protein extracts prepared from ovaries of various developmental stages indicated that otu-104 predominates in predifferentiated stages, while otu-98 is prevalent in differentiated egg chambers. Immunolocalization experiments demonstrated that otu protein is present in the cytoplasm of oogonial stem cells that populate third instar larvae and in all germ-line-derived cells until late in oogenesis. In stage 10 egg chambers, otu protein shifts to the subcortical region of nurse cells. This type of analysis also showed that upon formation of a 16-cell syncytium otu-104, but not otu-98, preferentially accumulates in the developing oocyte cytoplasm. The otu mutant protein does not show this pattern of enhanced accumulation, nor does it occur in ovaries of egalitarian and Bicaudal-D mutants, which are defective in oocyte determination. Thus, these studies indicate that the 104-kDa isoform is required for normal proliferation of female germline cells and perhaps for oocyte differentiation. The 98-kDa isoform appears to be dispensable but can provide an otu function needed for the completion of oocyte maturation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7851643     DOI: 10.1006/dbio.1995.1017

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  7 in total

1.  Robert C. King: an appreciation of his work.

Authors:  Pamela K Mulligan
Journal:  Genetics       Date:  2003-11       Impact factor: 4.562

2.  Structural basis for ubiquitin recognition by the Otu1 ovarian tumor domain protein.

Authors:  Troy Eugene Messick; Nathaniel Scott Russell; Ayaka Jennifer Iwata; Kathryn Lorenz Sarachan; Ramin Shiekhattar; John R Shanks; Francisca E Reyes-Turcu; Keith D Wilkinson; Ronen Marmorstein
Journal:  J Biol Chem       Date:  2008-02-12       Impact factor: 5.157

3.  stand still, a Drosophila gene involved in the female germline for proper survival, sex determination and differentiation.

Authors:  G Pennetta; D Pauli
Journal:  Genetics       Date:  1997-04       Impact factor: 4.562

4.  Genetic analysis of Drosophila melanogaster polytene chromosome region 44D-45F: loci required for viability and fertility.

Authors:  Stephanie E Mohr; Robert E Boswell
Journal:  Genetics       Date:  2002-04       Impact factor: 4.562

5.  Glorund interactions in the regulation of gurken and oskar mRNAs.

Authors:  Yossi Kalifa; Stephen T Armenti; Elizabeth R Gavis
Journal:  Dev Biol       Date:  2008-11-05       Impact factor: 3.582

6.  Drosophila germline sex determination: integration of germline autonomous cues and somatic signals.

Authors:  Leonie U Hempel; Rasika Kalamegham; John E Smith; Brian Oliver
Journal:  Curr Top Dev Biol       Date:  2008       Impact factor: 4.897

7.  OTUB1 overexpression in mesangial cells is a novel regulator in the pathogenesis of glomerulonephritis through the decrease of DCN level.

Authors:  Yan Zhang; Ruimin Hu; Huijuan Wu; Weina Jiang; Yu Sun; Yan Wang; Yanan Song; Tong Jin; Hongxia Zhang; Xin Mao; Zhonghua Zhao; Zhigang Zhang
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.